Interleukin-2 acutely induces protein leakage from the microcirculation

Journal of Surgical Research

Volumn 50, Issue 6, 1991, Pages 609-615

  Edwards, Michael J ^a   Schuschke, Dale A ^a   Abney, Deanna L ^a   Miller, Frederick N ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER; CONFERENCE PAPER; DRUG EFFICACY; DRUG TOXICITY; ENDOTHELIUM; ETIOLOGY; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; MICROCIRCULATION; MUSCLE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; SIDE EFFECT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMAL; BLOOD PROTEINS; CAPILLARY PERMEABILITY; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; INTERLEUKIN-2; MALE; MICROCIRCULATION; MICROSCOPY, FLUORESCENCE; MUSCLES; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T;

EID: 0025880753     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/0022-4804(91)90050-V     Document Type: Article

References (14)

1. Clinical effects and toxicity of interleukin-2 in patients with cancer
2. Interleukin-2 in cancer therapy
3. Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice
4. The rapid induction by interleukin-2 of pulmonary microvascular permeability
5. Effects of interleukin-2 on pulmonary and systemic transvascular fluid filtration
6. Microvascular responses in copper-deficient rats
7. On-line volume flow rate and velocity profile measurement for blood in microvessels
8. Application of the “two-slit” photometric technique to the measurement of microvascular volumetric flow rates
9. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin-2
10. A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin-2 or high dose interleukin-2 alone
11. The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells
12. Cardiopulmonary toxicity of adoptive immunotherapy
13. Exchange of substances through the capillary walls
14. Direct in vivo observations of embolic events in the microcirculation distal to a small-vessel anastomosis